Divested.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.
Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.
